Principal Financial Group Inc. Increases Stock Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)
Principal Financial Group Inc. boosted its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report) by 3.9% during ...
Hosted on MSN19h
Johnson & Johnson’s TREMFYA® Shows Promising Results in Ulcerative Colitis Patients
Johnson & Johnson (NYSE: JNJ) has announced positive results from the Phase 3 ASTRO study evaluating TREMFYA® (guselkumab) ...
Santé log21h
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
About duvakitug Duvakitug is a potential best-in-class human IgG1-λ2 monoclonal antibody that targets tumor necrosis factor (TNF)-like ligand 1A (TL1A), also known as TNF superfamily member 15 ...